Abstract We evaluated whether ovarian tissue cryopreservation (OTC) is a viable option for girls and young women who have already undergone hematopoietic stem cell transplantation (HSCT). We enrolled 142 patients who underwent OTC either before or after HSCT. Participants were categorized into three groups: “after HSCT group” (n = 16), “no-chemo group” before OTC (n = 75), and “chemo group” before OTC (n = 51).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Yanglu
Contact Yanglu, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack